InvestorsHub Logo
Post# of 252254
Next 10
Followers 834
Posts 119875
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 171434

Tuesday, 12/17/2013 8:33:52 PM

Tuesday, December 17, 2013 8:33:52 PM

Post# of 252254
Curious that Samsung Bioepis is pursuing Remicade and Enbrel FoB's in Europe, but apparently not Humira. Anyone care to speculate why?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.